Edition:
United Kingdom

People: Cipla Ltd (CIPL.NS)

CIPL.NS on National Stock Exchange of India

557.25INR
5:53am BST
Change (% chg)

Rs0.70 (+0.13%)
Prev Close
Rs556.55
Open
Rs556.85
Day's High
Rs559.65
Day's Low
Rs554.60
Volume
179,301
Avg. Vol
2,259,896
52-wk High
Rs678.45
52-wk Low
Rs483.75

Lankau, Peter 

Mr. Peter Lankau was an Additional Independent Director of the company. Mr. Lankau has graduated with Bachelors of Science in Biology from the State University of New York at Albany, USA. He has over 30 years of management experience in developing and commercializing pharmaceutical products. Mr. Lankau is currently a principal of Lankau Consulting LLC. He was previously Executive Chairman of the Board for Nautilus Neurosciences, Inc., Chairman & CEO of Logical Therapeutics, Inc. and President & CEO of Endo Pharmaceuticals Inc. Prior to Endo Pharmaceuticals Inc., he was VP, Sales and Marketing for Alpharma, Inc. He began his pharmaceutical career with Rhone-Poulenc Rorer, Inc. (now Sanofi). Mr. Lankau currently serves on the Board of Directors of ANI Pharmaceuticals, Inc. and Phosphagenics Limited and also on the Board of Advisors of Orchard Venture Partners, a life sciences venture capital firm.

Basic Compensation

Total Annual Compensation, INR 4,400,000
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR --
Fiscal Year Total, INR 4,400,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Yusuf Hamied

20,300,000

Umang Vohra

188,500,000

Samina Vaziralli

56,900,000

M. Hamied

21,000,000

Kedar Upadhye

25,100,000

Rajendra Chopra

16,800,000
As Of  31 Mar 2018